3 research outputs found
Overriding adaptive resistance to sorafenib through combination therapy with Src homology 2 domainâcontaining phosphatase 2 blockade in hepatocellular carcinoma
Title on authorâs file: Overriding adaptive resistance to sorafenib via combination therapy with SHP2 blockade in hepatocellular carcinoma202308 bckwAccepted ManuscriptRGCPublishe
EPHB2 activates β-catenin to enhance cancer stem cell properties and drive sorafenib resistance in hepatocellular carcinoma
202106 bcvcAuthorâs OriginalRGCRGC GRF 15103817, Theme-based Research Scheme project (T12-704/16-R )Publishe